Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,857 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of combination therapy with statins and ezetimibe on proinflammatory cytokines: A systematic review and meta-analysis of randomized controlled trials.
Mostafa Arabi S, Sadat Bahrami L, MalekAhmadi M, Chambari M, Milkarizi N, Orekhov AN, Sahebkar A. Mostafa Arabi S, et al. Among authors: sahebkar a. Int Immunopharmacol. 2022 Dec;113(Pt B):109477. doi: 10.1016/j.intimp.2022.109477. Epub 2022 Nov 20. Int Immunopharmacol. 2022. PMID: 36417822 Review.
Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial.
Gholinataj Jelodar M, Rafieian S, Saghafi F, Hadad Zedegan N, Birjandi B, Rafieian S, Allah Dini A, Dehghanpour H, Khalaj F, Zare S, Dehghan Chenari H, Hajimaghsoudi M, Mojtaba Sohrevardi S, Mirzaei S, Jamialahmadi T, Atkin SL, Sahebkar A. Gholinataj Jelodar M, et al. Among authors: sahebkar a. Int Immunopharmacol. 2023 Feb;115:109623. doi: 10.1016/j.intimp.2022.109623. Epub 2022 Dec 21. Int Immunopharmacol. 2023. PMID: 36577157 Free PMC article. Review.
The effect of l-carnitine supplementation on mortality and clinical outcomes in ventilator-dependent critically ill patients with obesity and COVID-19: Protocol for a randomized double-blind placebo-controlled trial.
Arabi SM, Hadi S, Gholambareshi P, Bahrami LS, Hazrati E, Mirghazanfari SM, Sahebkar A, Hadi V. Arabi SM, et al. Among authors: sahebkar a. Contemp Clin Trials Commun. 2023 Apr;32:101082. doi: 10.1016/j.conctc.2023.101082. Epub 2023 Jan 31. Contemp Clin Trials Commun. 2023. PMID: 36742110 Free PMC article.
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials.
Patoulias D, Popovic DS, Stoian AP, Janez A, Sahebkar A, Rizzo M. Patoulias D, et al. Among authors: sahebkar a. J Diabetes Complications. 2023 Aug;37(8):108529. doi: 10.1016/j.jdiacomp.2023.108529. Epub 2023 Jun 7. J Diabetes Complications. 2023. PMID: 37301063 Review.
Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP).
Katsiki N, Mikhailidis DP, Bajraktari G, Miserez AR, Cicero AFG, Bruckert E, Serban MC, Mirrakhimov E, Alnouri F, Reiner Ž, Paragh G, Sahebkar A, Banach M; International Lipid Expert Panel (ILEP). Katsiki N, et al. Among authors: sahebkar a. Pharmacol Res. 2020 May;155:104719. doi: 10.1016/j.phrs.2020.104719. Epub 2020 Feb 19. Pharmacol Res. 2020. PMID: 32087236 Review.
1,857 results